We're excited to share that Omios Biologics has been accepted into the NYU Tech Venture Accelerator (NYU-TVA) program and has already begun participating! This opportunity will provide us with valuable resources and guidance as we continue to develop our innovative oncolytic viral immunotherapies.?We're eager to collaborate with NYU's researchers and entrepreneurs to further advance our cancer-fighting technologies. We appreciate the support of the NYU-TVA program and look forward to a productive collaboration.?#OmiosBio #NYUTVA #CancerImmunotherapy #OncolyticViruses #Biotech
关于我们
Omios Biologics is an Immuno- Gene Therapy company developing oncolytic vaccine and systemic gene delivery platforms addressing the needs of patients with solid tumors. Our patented technologies harness the deficient innate immune response in cancer cells to generate maximum cancer selectivity and a rationally designed Immunogenic Cell Death to prime the immune system against the patient's own tumor antigens. In addition, our systemic vectors deliver a powerful proprietary therapeutic payload directly to the tumor and metastases.
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Alameda，CA
- 类型
- 私人持股
- 创立
- 2021
- 领域
- oncolytic vaccine、oncolytic virus immunotherapy、cancer vaccine、Immunogenic Cell Death、Innate immune response、Cancer surveillance、systemic delivery和gene delivery
地点
-
主要
获取路线
US，CA，Alameda，94501
Omios Biologics员工
动态
-
Omios Biologics is thrilled to announce that we've officially graduated from the NSF I-Corps program! This intensive experience has been invaluable, enriched by over a 100 interviews with key stakeholders, drug developers and clinicians. We're grateful for the guidance of our mentors Laurence Nore and Luke Tso, PharmD, BCPS, and the continuous support of the NSF. With a more refined business model and a validated go-to-clinic strategy, we continue to develop our next-generation oncolytic virus immunotherapy for patients in need. #oncolyticvirus #immunogenetherapy #viralimmunotherapy #immunotherapy #Cancervaccine #cancertherapy #genedelivery #biotech #NSF #Icorps #startup #innovation.?
-